Foresite Capital Management IV, LLC - THERAPEUTICS ACQUISITION COR ownership

THERAPEUTICS ACQUISITION COR's ticker is RACA and the CUSIP is 88339T103. A total of 19 filers reported holding THERAPEUTICS ACQUISITION COR in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Foresite Capital Management IV, LLC ownership history of THERAPEUTICS ACQUISITION COR
ValueSharesWeighting
Q1 2021$3,679,000
-24.5%
350,0000.0%0.44%
-16.6%
Q4 2020$4,872,000
-3.2%
350,0000.0%0.53%
-53.4%
Q3 2020$5,033,000350,0001.14%
Other shareholders
THERAPEUTICS ACQUISITION COR shareholders Q3 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,000,000$14,380,0001.34%
Foresite Capital Management IV, LLC 350,000$5,033,0001.14%
Logos Global Management LP 500,000$7,190,0000.92%
BVF INC/IL 1,000,000$14,380,0000.78%
Boxer Capital, LLC 1,500,000$21,570,0000.74%
Perceptive Advisors 1,500,000$21,570,0000.32%
Cormorant Asset Management, LP 500,000$7,190,0000.28%
Avoro Capital Advisors LLC 1,000,000$14,380,0000.20%
RTW INVESTMENTS, LP 490,000$7,046,0000.17%
Monashee Investment Management LLC 47,271$680,0000.15%
View complete list of THERAPEUTICS ACQUISITION COR shareholders